CERE Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $147,510,898.72
Insider Selling (Last 12 Months): $12,535,500.35

Cerevel Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cerevel Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cerevel Therapeutics Share Price & Price History

Current Price: $42.90
Price Change: Price Increase of +0.2 (0.47%)
As of 07/19/2024 01:00 AM ET

This chart shows the closing price history over time for CERE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cerevel Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2024Anthony ColesDirectorSell25,000$41.18$1,029,500.0025,928View SEC Filing Icon  
5/10/2024Anthony ColesDirectorSell50,000$42.10$2,105,000.0015,638View SEC Filing Icon  
3/4/2024Anthony ColesDirectorSell50,000$41.01$2,050,500.0015,638View SEC Filing Icon  
2/29/2024Anthony ColesDirectorSell50,000$41.16$2,058,000.0015,638View SEC Filing Icon  
2/7/2024John RengerInsiderSell2,161$41.54$89,767.946,370View SEC Filing Icon  
2/7/2024Anthony ColesDirectorSell2,506$41.54$104,099.2415,638View SEC Filing Icon  
12/26/2023Ramiro SanchezInsiderSell10,000$42.47$424,700.0014,673View SEC Filing Icon  
12/22/2023Kenneth DiPietroInsiderSell8,000$41.45$331,600.0024,663View SEC Filing Icon  
12/20/2023Mark BodenraderInsiderSell7,889$41.42$326,762.3817,724View SEC Filing Icon  
12/20/2023Susan AltschullerCFOSell13,808$41.42$571,927.3616,913View SEC Filing Icon  
12/7/2023Scott AkamineInsiderSell10,000$41.37$413,700.00513View SEC Filing Icon  
12/5/2023Scott AkamineInsiderSell7,500$35.00$262,500.00513View SEC Filing Icon  
11/8/2023Anthony ColesDirectorSell100$25.16$2,516.002,704View SEC Filing Icon  
11/3/2023Anthony ColesDirectorSell61,401$25.43$1,561,427.432,704View SEC Filing Icon  
10/16/2023Bain Capital Investors LlcMajor ShareholderBuy5,480,052$22.81$124,999,986.1265,679,781View SEC Filing Icon  
10/16/2023Perceptive Advisors LlcDirectorBuy876,808$22.81$19,999,990.4810,794,876View SEC Filing Icon  
9/7/2023Anthony ColesDirectorSell50,000$24.07$1,203,500.002,704View SEC Filing Icon  
8/4/2023Paul D. BurgessInsiderBuy21,880$22.93$501,708.4021,880View SEC Filing Icon  
8/3/2023Ronald C. Renaud, Jr.CEOBuy83,857$23.96$2,009,213.7283,857View SEC Filing Icon  
7/11/2023Anthony ColesDirectorSell50,000$30.03$1,501,500.002,704View SEC Filing Icon  
6/15/2023Marijn E DekkersDirectorSell200,000$34.43$6,886,000.00402,326View SEC Filing Icon  
6/2/2023Mark BodenraderInsiderSell1,895$32.95$62,440.255,522View SEC Filing Icon  
6/1/2023Anthony ColesCEOSell50,000$32.60$1,630,000.002,704View SEC Filing Icon  
5/4/2023Anthony ColesCEOSell50,000$31.47$1,573,500.002,704View SEC Filing Icon  
4/11/2023Anthony ColesCEOSell50,000$25.06$1,253,000.002,704View SEC Filing Icon  
3/3/2023Anthony ColesCEOSell3,000$27.19$81,570.002,704View SEC Filing Icon  
2/7/2023Anthony ColesCEOSell50,000$33.13$1,656,500.002,704View SEC Filing Icon  
1/5/2023Anthony ColesCEOSell50,000$29.94$1,497,000.002,704View SEC Filing Icon  
12/9/2022Anthony ColesCEOSell50,000$26.67$1,333,500.002,704View SEC Filing Icon  
10/4/2022John RengerInsiderSell25,000$30.00$750,000.002,704View SEC Filing Icon  
9/12/2022Deval L. PatrickDirectorSell47,705$30.78$1,468,359.90View SEC Filing Icon  
9/8/2022Abraham CeesayPresidentSell19,210$32.50$624,325.00View SEC Filing Icon  
8/22/2022Abraham CeesayPresidentSell9,605$32.50$312,162.50View SEC Filing Icon  
8/16/2022Perceptive Advisors LlcDirectorBuy1,425,000$35.00$49,875,000.006,511,727View SEC Filing Icon  
8/10/2022John RengerInsiderSell55,000$40.50$2,227,500.002,704View SEC Filing Icon  
7/20/2022John RengerInsiderSell25,000$30.00$750,000.002,704View SEC Filing Icon  
7/5/2022John RengerInsiderSell25,000$30.00$750,000.002,704View SEC Filing Icon  
4/13/2022John RengerInsiderSell45,000$34.65$1,559,250.001,980View SEC Filing Icon  
3/29/2022John RengerInsiderSell10,000$35.00$350,000.00View SEC Filing Icon  
3/18/2022John RengerInsiderSell20,000$32.50$650,000.00View SEC Filing Icon  
3/16/2022John RengerInsiderSell25,000$30.00$750,000.00View SEC Filing Icon  
2/9/2022John RengerInsiderSell25,000$30.00$750,000.00View SEC Filing Icon  
12/27/2021John RengerInsiderSell4,127$35.00$144,445.00View SEC Filing Icon  
12/23/2021John RengerInsiderSell5,873$35.00$205,555.00View SEC Filing Icon  
12/21/2021John RengerInsiderSell7,300$32.50$237,250.00View SEC Filing Icon  
12/17/2021John RengerInsiderSell7,122$32.50$231,465.00View SEC Filing Icon  
12/15/2021John RengerInsiderSell25,000$30.02$750,500.00View SEC Filing Icon  
11/10/2021John RengerInsiderSell55,000$39.86$2,192,300.00View SEC Filing Icon  
8/25/2021Perceptive Advisors LlcDirectorBuy61,387$28.57$1,753,826.59View SEC Filing Icon  
8/23/2021Perceptive Advisors LlcDirectorBuy44,437$25.78$1,145,585.86View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cerevel Therapeutics (NASDAQ:CERE)

87.73% of Cerevel Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CERE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cerevel Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/12/2024SG Americas Securities LLC29,424$1.20M0.0%+508.8%0.016%Search for SEC Filing on Google Icon
7/5/2024Thurston Springer Miller Herd & Titak Inc.3,107$0.13M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/17/2024Comerica Bank743$31K0.0%-98.9%0.000%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System122,437$5.18M0.0%+63.9%0.067%Search for SEC Filing on Google Icon
5/16/2024Black Maple Capital Management LP15,702$0.66M0.4%N/A0.009%Search for SEC Filing on Google Icon
5/16/2024Blackstone Inc.35,196$1.49M0.0%+142.0%0.019%Search for SEC Filing on Google Icon
5/15/2024Public Employees Retirement Association of Colorado9,005$0.38M0.0%-17.8%0.005%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD335,357$14.18M0.0%-53.5%0.185%Search for SEC Filing on Google Icon
5/15/2024GABELLI & Co INVESTMENT ADVISERS INC.447,695$18.92M3.3%+62.5%0.247%Search for SEC Filing on Google Icon
5/15/2024Gabelli Funds LLC643,859$27.22M0.2%+38.3%0.355%Search for SEC Filing on Google Icon
5/15/2024Gamco Investors INC. ET AL68,837$2.91M0.0%+10.5%0.038%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC300,000$12.68M1.6%-60.0%0.165%Search for SEC Filing on Google Icon
5/14/2024Capital International Investors253,495$10.72M0.0%-70.7%0.140%Search for SEC Filing on Google Icon
5/14/2024Natixis71,789$3.04M0.0%-40.5%0.040%Search for SEC Filing on Google Icon
5/14/2024Healthcare of Ontario Pension Plan Trust Fund828,776$35.03M0.1%+151.1%0.456%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.35,294$1.49M0.0%+1.6%0.019%Search for SEC Filing on Google Icon
5/14/2024Lake Street Advisors Group LLC83,857$3.55M0.2%-65.7%0.046%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.7,463,911$315.50M0.0%+1.2%4.111%Search for SEC Filing on Google Icon
5/9/2024Chicago Capital Management LLC39,437$1.67M1.8%+192.1%0.022%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System14,070$0.60M0.0%-22.5%0.008%Search for SEC Filing on Google Icon
5/8/2024Entropy Technologies LP16,131$0.68M0.1%N/A0.009%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC611$26K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.15,607$0.66M0.0%N/A0.009%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank143,200$6.05M0.0%+2.5%0.079%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC4,833$0.20M0.0%-80.3%0.003%Search for SEC Filing on Google Icon
5/7/2024Deuterium Capital Management LLC12,572$0.53M1.0%N/A0.007%Search for SEC Filing on Google Icon
5/2/2024Tokio Marine Asset Management Co. Ltd.387,800$16.39M0.8%N/A0.214%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.31,526$1.33M0.0%-13.3%0.017%Search for SEC Filing on Google Icon
3/29/2024Kapitalo Investimentos Ltda180,000$7.63M1.6%N/A0.099%Search for SEC Filing on Google Icon
3/22/2024PNC Financial Services Group Inc.6,500$0.28M0.0%-31.6%0.004%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.7,374,970$312.70M0.0%+15.8%4.062%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP35,578$1.51M0.0%-25.5%0.020%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.532,757$22.59M0.0%+64.2%0.294%Search for SEC Filing on Google Icon
2/26/2024Centaurus Financial Inc.2,800$0.12M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC5,803$0.25M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC10,965,193$464.92M10.4%+8.7%6.044%Search for SEC Filing on Google Icon
2/15/2024Governors Lane LP364,400$15.45M1.6%N/A0.202%Search for SEC Filing on Google Icon
2/14/2024Twin Securities Inc.232,705$9.87M10.4%N/A0.129%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP276,888$11.74M0.4%-56.9%0.154%Search for SEC Filing on Google Icon
2/14/2024PenderFund Capital Management Ltd.9,400$0.40M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC7,555,555$320.36M4.4%+690.7%4.191%Search for SEC Filing on Google Icon
2/14/2024Water Island Capital LLC588,100$24.94M2.6%N/A0.326%Search for SEC Filing on Google Icon
2/13/2024Bain Capital Investors LLC65,679,781$2.78B60.4%+9.1%36.432%Search for SEC Filing on Google Icon
2/13/2024GABELLI & Co INVESTMENT ADVISERS INC.275,500$11.68M2.2%N/A0.153%Search for SEC Filing on Google Icon
2/13/2024Gabelli Funds LLC465,621$19.74M0.2%N/A0.258%Search for SEC Filing on Google Icon
2/13/2024Capital International Investors863,786$36.63M0.0%N/A0.479%Search for SEC Filing on Google Icon
2/13/2024Lake Street Advisors Group LLC244,309$10.36M0.7%+191.3%0.136%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC750,000$31.80M5.9%+9.5%0.416%Search for SEC Filing on Google Icon
2/13/2024Carmignac Gestion44,181$1.87M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC141,477$6M0.0%-28.9%0.078%Search for SEC Filing on Google Icon
2/12/2024Olympiad Research LP47,304$2.01M1.6%N/A0.026%Search for SEC Filing on Google Icon
2/12/2024Allianz Asset Management GmbH144,400$6.12M0.0%N/A0.080%Search for SEC Filing on Google Icon
2/12/2024Hsbc Holdings PLC408,032$17.32M0.0%N/A0.226%Search for SEC Filing on Google Icon
2/9/2024Westfield Capital Management Co. LP785,494$33.31M0.2%-19.4%0.436%Search for SEC Filing on Google Icon
2/9/2024Aigen Investment Management LP8,215$0.35M0.1%N/A0.005%Search for SEC Filing on Google Icon
2/9/2024PNC Financial Services Group Inc.6,500$0.28M0.0%-31.6%0.004%Search for SEC Filing on Google Icon
2/9/2024Norges Bank685,694$29.07M0.0%N/A0.380%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.27,117$1.15M0.0%+1.6%0.015%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas16,032$0.68M0.0%-10.0%0.009%Search for SEC Filing on Google Icon
2/7/2024Versor Investments LP108,657$4.61M0.9%N/A0.060%Search for SEC Filing on Google Icon
2/7/2024Alpine Associates Management Inc.1,644,100$69.71M3.6%N/A0.912%Search for SEC Filing on Google Icon
2/7/2024Kellner Capital LLC20,300$0.86M1.6%N/A0.011%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.7,599$0.32M0.0%-25.7%0.004%Search for SEC Filing on Google Icon
2/7/2024Segantii Capital Management Ltd594,519$25.21M1.3%N/A0.330%Search for SEC Filing on Google Icon
2/6/2024Pacific Capital Wealth Advisors Inc.1,672$71K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.649,333$27.53M0.0%+25.5%0.360%Search for SEC Filing on Google Icon
2/6/2024BCK Capital Management LP22,000$0.93M0.9%N/A0.012%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank10,027$0.43M0.0%+8.8%0.006%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank139,700$5.92M0.0%+1.3%0.077%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.11,592$0.49M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund28,535$1.21M0.0%+5.1%0.016%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB16,200$0.69M0.0%+39.7%0.009%Search for SEC Filing on Google Icon
1/31/2024Calamos Advisors LLC305,303$12.95M0.1%N/A0.169%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank13,170$0.56M0.0%+9.0%0.007%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio9,800$0.42M0.0%-3.9%0.005%Search for SEC Filing on Google Icon
1/25/2024International Assets Investment Management LLC55,120$23.37M0.1%N/A0.031%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.36,363$1.54M0.0%+6.2%0.020%Search for SEC Filing on Google Icon
1/24/2024International Assets Investment Management LLC55,120$23.37M0.0%N/A0.031%Search for SEC Filing on Google Icon
1/24/2024Arizona State Retirement System19,816$0.84M0.0%+10.9%0.011%Search for SEC Filing on Google Icon
1/23/2024GAM Holding AG5,000$0.21M0.0%N/A0.003%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.299,891$12.72M0.0%N/A0.166%Search for SEC Filing on Google Icon
1/12/2024FNY Investment Advisers LLC8,000$0.34M0.4%N/A0.004%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC24,487$1.04M0.0%N/A0.014%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.6,371,376$139.09M0.0%+12.5%3.534%Search for SEC Filing on Google Icon
12/7/2023Hudson Bay Capital Management LP50,000$1.09M0.0%N/A0.028%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP47,760$1.04M0.0%N/A0.026%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.307,743$6.72M0.0%-0.5%0.171%Search for SEC Filing on Google Icon
11/22/2023Polar Capital Holdings Plc10,762$0.24M0.0%-98.8%0.006%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.41,850$0.91M0.0%+304.6%0.023%Search for SEC Filing on Google Icon
11/15/2023Rock Springs Capital Management LP2,529,116$55.21M1.5%+0.6%1.403%Search for SEC Filing on Google Icon
11/15/2023Lake Street Advisors Group LLC83,857$1.83M0.1%N/A0.047%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.1,505,976$32.88M0.1%+100.8%0.835%Search for SEC Filing on Google Icon
11/15/2023Alps Advisors Inc.116,263$2.54M0.0%+0.9%0.064%Search for SEC Filing on Google Icon
11/15/2023Affinity Asset Advisors LLC685,061$14.96M4.2%+24.6%0.380%Search for SEC Filing on Google Icon
11/14/2023Avidity Partners Management LP643,000$14.04M0.6%+28.3%0.357%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP14,397$0.31M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/14/2023Westfield Capital Management Co. LP974,483$21.27M0.1%+69.3%0.541%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC33,984$0.74M0.0%+4.2%0.019%Search for SEC Filing on Google Icon
11/13/2023Dark Forest Capital Management LP12,247$0.27M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/13/2023FMR LLC23,623,144$515.69M0.0%+0.6%13.104%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cerevel Therapeutics logo
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Read More on Cerevel Therapeutics

Today's Range

Now: $42.90
Low: $42.53
High: $42.91

50 Day Range

MA: $41.23
Low: $38.96
High: $42.90

52 Week Range

Now: $42.90
Low: $19.59
High: $43.59

Volume

2,241,590 shs

Average Volume

2,552,622 shs

Market Capitalization

$7.82 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

Who are the company insiders with the largest holdings of Cerevel Therapeutics?

Cerevel Therapeutics' top insider investors include:
  1. Bain Capital Investors Llc (Major Shareholder)
  2. Perceptive Advisors Llc (Director)
  3. Marijn E Dekkers (Director)
  4. Ronald C Renaud Jr (CEO)
  5. N Anthony Coles (Director)
  6. Kenneth Dipietro (Insider)
  7. Paul D Burgess (Insider)
  8. Mark Bodenrader (Insider)
  9. Susan Altschuller (CFO)
  10. Ramiro Sanchez (Insider)
  11. John Renger (Insider)
  12. N Anthony Coles (CEO)
  13. Scott Akamine (Insider)
  14. Abraham Ceesay (President)
  15. Deval L Patrick (Director)
Learn More about top insider investors at Cerevel Therapeutics.

Who are the major institutional investors of Cerevel Therapeutics?

Cerevel Therapeutics' top institutional shareholders include:
  1. SG Americas Securities LLC — 0.02%
  2. Thurston Springer Miller Herd & Titak Inc. — 0.00%
Learn More about top institutional investors of Cerevel Therapeutics stock.

Which major investors are buying Cerevel Therapeutics stock?

During the previous quarter, CERE stock was acquired by institutional investors including:
  1. SG Americas Securities LLC
  2. Thurston Springer Miller Herd & Titak Inc.
Within the previous year, these company insiders have bought Cerevel Therapeutics stock:
  1. Bain Capital Investors Llc (Major Shareholder)
  2. Perceptive Advisors Llc (Director)
  3. Marijn E Dekkers (Director)
  4. Ronald C Renaud Jr (CEO)
Learn More investors buying Cerevel Therapeutics stock.